Get more replies from employers
Send a job-specific resume in minutes.
FDA/CDER/OPQ in White Oak, Maryland offers an ORISE fellowship focused on regulatory science research. The fellow will work on AI/ML methods, mechanistic modeling, and data-driven approaches to improve pharmaceutical product quality and manufacturing processes.
Collaboration with multidisciplinary FDA teams is emphasized to develop credible modeling strategies and regulatory-ready insights. The appointment is for one year, full-time, with a monthly stipend commensurate with education and
U.S. Food and Drug Administration (FDA)
FDA-CDER-2026-0141
9/25/2026 3:00:00 PM Eastern Time Zone
A research opportunity is available immediately with the Food and Drug Administration (FDA),Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (FDA/CDER/OPQ), located in White Oak, Maryland.
The Center for Drug Evaluation and Research (CDER) performs an essential public health task by making sure that safe and effective drugs are available to improve the health of people in the United States. As part of the U.S. Food and Drug Administration (FDA), CDER regulates over-the-counter and prescription drugs, including biological therapeutics and generic drugs. This effort covers more than just medicines.
The U.S. Food and Drug Administration’s Center for Drug Evaluation and Research, Office of Pharmaceutical Quality (FDA/CDER/OPQ), is seeking an ORISE fellow to gain experience in regulatory science research supporting pharmaceutical product quality. The project will focus on the development and application of artificial intelligence, machine learning, mechanistic modeling, mathematical modeling, and simulation methods to pharmaceutical manufacturing and product characterization.
The fellow will collaborate with and learn from multidisciplinary FDA scientists to develop data-driven and first-principles models and evaluate how they can be used to improve understanding of pharmaceutical products and manufacturing processes. The research will contribute to the development of scientific principles, evaluation strategies, and best practices for the use of computational models and AI-enabled methods in pharmaceutical quality.
The mentor for this opportunity is Jianan Zhao (jianan.zhao@fda.hhs.gov). If you have questions about the nature of the research, please contact the mentor.
September 2026. Start date is flexible and will depend on a variety of factors.
The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds.
The appointment is full time.
The participant will receive a monthly stipend commensurate with educational level and experience.
This opportunity is available to U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals. Non-U.S. citizen applicants should refer to the Guidelines for Non-U.S. Citizens Details page of the program website for information about the valid immigration statuses that are acceptable for program participation.
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.
If an ORISE Fellow, to include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest the financial interest or terminate the relationship, then the individual is not placed at FDA. For additional requirements, see FDA Ethics for Nonemployee Scientists.
The qualified candidate should be currently pursuing or have received a master's or doctoral degree in the one of the relevant fields.
Ashley
I am a U.S. citizen, or I have lived in the United States for at least 36 out of the past 60 months. (36 months do not have to be consecutive.) and I have read the FDA Ethics Requirements.